Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy
In this (cohort) study, 205,414 people between the ages of 20 and 69 recruited from all over Germany in the years 2014-2019 will be medically examined and questioned about their lifestyle habits (e.g. physical activity, smoking, diet, occupation). In addition, blood samples and other biomaterial will be taken from all study participants and stored in a central biosample bank for later research projects. After 5 years, all participants are again invited to the study centres for an examination and a second interview. In the course of the 10 to 20-year follow-up, some participants will naturally develop certain diseases that can then be linked to the data collected. The study therefore offers unique potential for a variety of scientific investigations. It will provide valuable insights into how genetic factors, environmental conditions, social environment and lifestyle interact in the development of diseases. The findings will be used to derive strategies for better prevention and treatment of the most common diseases. The third funding phase began on 1 May 2023 and will last until 30 April 2028. The donor conference consisting of the federal government and the 13 federal states with study centres sees a continuation of the NAKO Health Study as a goal.
The project also allows differentiated analyses of the health of people with a migration background. The NAKO Health Study contains two larger subpopulations: a so-called "Aussiedler cohort" with n=1,700 people with a Russian migration background and a subgroup with n=1,400 people with a Turkish migration background. This enables cooperation with BiB research area 2 "Migration and Mobility", for example, which deals with the well-being and subjective health of migrants, among other things. Furthermore, research questions on the spatial mobility of the NAKO population can be answered as part of the relocation history.
The sub-project "Mortality Follow-Up of the NAKO Health Study" at the BIB pursues three objectives: (1) a regular rolling vital status survey of all study participants; (2) for deceased subjects, the collection and validation of the cause(s) of death via the information in the death certificate and other clinical and other documentation, whereby increasingly available socio-demographic and employment-related characteristics can be linked to these cases (including the German Classification of Occupations of 2010); (3) the conceptual preparation of a non-responder mortality follow-up (subject to funding approval), whereby a statistical twin (same year of birth, same year of invitation, same gender, same study centre) is drawn from the pool of selected but not recruited addresses for each recruited and investigated case. By comparing the active cases with their statistical twins, sample bias can be recorded and the findings from the active cases can be extrapolated to the total German population.
Outstanding features of the Mortality Follow-Up include the very extensive validation procedures for cause of death information from various data sources, the support of multi-causal cause of death analyses and the direct linkability with other study parameters such as biomarkers, imaging data and other physical health parameters. The mortality follow-up research team is thus setting new standards that are also unique in international comparison.
The NAKO project serves to collect personal data on health status and socio-economic characteristics. In the context of mortality follow-up at the BIB, the vital status of the participants is regularly checked and the cause of death is determined as precisely as possible in the case of deceased persons. The project is based on the highest international quality standards in order to ensure international comparability. In addition, as part of the relocation history, all relocations of NAKO participants since the year 2000 and up to the present are to be analysed for scientific purposes. This additional information will then be incorporated into the environmental database of the NAKO Health Study.
since 07/2015
Helmholtz-Zentrum München; Max-Delbrück-Centrum für Molekulare Medizin; Charité – Universitätsmedizin Berlin; Deutsches Institut für Ernährungsforschung; Leibniz-Institut für Präventionsforschung und Epidemiologie – BIPS GmbH; Deutsches Diabetes Zentrum; IUF – Leibniz-Institut für umweltmedizinische Forschung GmbH; Universität Duisburg-Essen; Universität Freiburg; Universität Halle-Wittenberg; Universitätsklinikum Hamburg-Eppendorf; Helmholtz-Zentrum für Infektionsforschung; Universität Kiel; Universität Heidelberg; Universität Münster; Universität Greifswald; Universität Regensburg; Deutsches Krebsforschungszentrum; Krebsregister Saarland; Robert Koch-Institut; Ludwig-Maximilians-Universität München; Universität Magdeburg; Fraunhofer MEVIS
UK Biobank; Nuffield Department of Population Health, Oxford University; University of Manchester; University of Michigan; University of California, Los Angeles; Emory University, Atlanta; Institute of Health Metrics and Evaluation, University of Washington
BiB self financing, Federal Ministry of Education and Research (BMBF), Bundesländer (außer Rheinland-Pfalz, Hessen, Thüringen), Helmholtz-Gemeinschaft